Best hospitals in the United States for pancreatic cancer: An evidence-based care comparison

What distinguishes leading pancreatic cancer hospitals

Leading pancreatic cancer hospitals generally organize care around specialists who routinely evaluate pancreatic tumors, including surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists, radiologists, pathologists, genetic specialists, and supportive-care professionals. The National Pancreatic Cancer Foundation describes specialized expertise, multidisciplinary coordination, advanced technology, and patient-centered services as important characteristics of high-quality centers. These capabilities matter because treatment decisions depend on tumor location, stage, resectability, overall health, and whether disease has spread. 1 16

• Pancreatic surgery and perioperative care
• Specialized imaging and pathology review
• Systemic therapy, radiation, and molecular evaluation
• Genetic counseling, symptom management, and nurse navigation
• Clinical-trial screening and second-opinion review

Hospitals frequently recognized for national cancer care

National cancer rankings provide a broad comparison rather than a pancreatic-specific outcome measure. In the reported 2026 to 2027 U.S. News cancer-care ranking, MD Anderson Cancer Center was listed first, followed by Memorial Sloan Kettering Cancer Center, Dana-Farber Brigham Cancer Center, Mayo Clinic Rochester, Massachusetts General Hospital, Johns Hopkins Hospital, the Hospital of the University of Pennsylvania, Northwestern Memorial Hospital, Stanford Hospital, and a tie involving Mount Sinai and UCSF. The ranking evaluated patient outcomes, structure and process, expert opinion, patient experience, and transparency. 4 5

Why NCI designation and center accreditation matter

The National Cancer Institute describes NCI-designated cancer centers as institutions recognized for scientific leadership, cancer research, and multidisciplinary programs. A designation can indicate substantial research infrastructure and access to investigators, but it does not establish that one hospital is appropriate for every patient or diagnosis. The National Pancreas Foundation uses a separate review process for pancreatic cancer centers, considering specialty care alongside pain management, psychosocial support, and other whole-patient services. 8 1 6

Evidence supplied from a 2026 Annals of Surgical Oncology study examined 12,971 older adults with stage I to III pancreatic ductal adenocarcinoma in the SEER-Medicare database from 2005 through 2019. The study reported higher nurse-to-bed ratios at NCI-designated and non-NCI Commission on Cancer centers than at non-designated centers. These findings describe associations in a defined population, not a guarantee of survival or surgical quality at an individual hospital. 7

Pancreatic surgery volume and second opinions

Surgical volume is especially relevant when a Whipple procedure, distal pancreatectomy, or another complex operation is being considered. The supplied research identifies surgical volume, multidisciplinary review, and second opinions as concrete issues for comparison, while emphasizing that pancreatic surgery is technically demanding. Patients and families can ask how many pancreatic operations the surgical team performs, how outcomes are measured, how complications are managed, and whether imaging is reviewed by specialists before a treatment plan is finalized. 2 1

• Ask whether the tumor is considered resectable, borderline resectable, locally advanced, or metastatic.
• Ask whether the case is reviewed by a formal multidisciplinary conference.
• Ask about surgeon-specific volume and complication reporting.
• Ask whether outside pathology and imaging can receive specialist review.
• Ask how chemotherapy, radiation, surgery, and recovery are coordinated.

Research, molecular testing, and clinical trials

Research-oriented hospitals may offer studies involving early detection, novel medicines, targeted treatment, immunotherapy, precision medicine, or combinations of established therapies. MD Anderson’s Pancreatic Cancer Moon Shot focuses on pancreatic cancer research, early detection, prevention, and treatment innovation. Penn reports focus areas that include early detection, clinical trials, novel therapies, and personalized treatment, while Johns Hopkins describes a precision-medicine program integrating genetics, research, and trials. 9 3 10

Trial participation is not automatic. Eligibility can depend on stage, prior treatment, laboratory results, organ function, molecular findings, performance status, and geographic or scheduling requirements. Molecular testing may identify information relevant to targeted treatment or trial screening, but it does not ensure that a matched therapy exists. Treatment choices remain dependent on the pathology, imaging, clinical condition, and recommendations of the treating oncology team. 11 16

Examples of specialized regional programs

Specialized pancreatic programs exist across different regions, so a nationally prominent cancer hospital is not the only possible setting for expert care. UCSF describes a Pancreas Center offering multidisciplinary evaluation and complex pancreatic surgery. Dana-Farber lists medical oncology, surgery, radiation oncology, genetics, clinical research, and supportive services. Duke describes coordination among surgery, medical oncology, radiation oncology, gastroenterology, radiology, pathology, and genetics. Cleveland Clinic similarly identifies surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and clinical trials as possible components depending on disease characteristics. 12 13 15 14

MUSC Hollings Cancer Center illustrates how regional accreditation can add context: the National Pancreas Foundation designated MUSC Hollings as a pancreatic cancer Center of Excellence, and MUSC Health as a Center of Excellence for pancreatitis. The organization reported that these were the only such centers in South Carolina at the time of publication. Designation can help identify infrastructure, but distance, insurance network rules, travel burden, caregiver availability, and continuity with local clinicians remain practical considerations. 6 1

Risks, access barriers, and questions to document

Traveling to a major center can create logistical friction, including transportation, lodging, time away from work, caregiver coordination, insurance authorization, and the need to receive portions of care locally. The National Pancreatic Cancer Foundation identifies travel assistance, financial assistance, navigation support, telemedicine, and partnerships between local hospitals and specialty centers as ways patients may address geographic barriers. Availability and eligibility vary, so these resources should be verified directly with the relevant organization or care team. 1

A careful comparison should avoid treating a ranking position as a personalized recommendation. The most useful record includes the center’s NCI or pancreas-specific designation, pancreatic surgical experience, multidisciplinary process, clinical-trial screening, molecular-testing policy, supportive care, second-opinion procedures, expected appointment sequence, and communication plan with local clinicians. Stage and resectability can change the relative importance of surgery, systemic therapy, radiation, symptom control, or trial evaluation, making an individualized review more informative than a simple national list. 8 16 2

Sources

1. National Pancreatic Cancer Foundation, “The Best Pancreatic Cancer Treatment Centers”
2. My Medicine Advisor, “Pancreatic Cancer Treatment Center: Volume Is Key”
3. Penn Medicine, “Pancreatic Cancer Care”
4. Becker’s Oncology, “U.S. News’ top cancer hospitals”
5. Healio, “UT MD Anderson once again named nation’s best cancer hospital”
6. MUSC Hollings Cancer Center, “MUSC named center of excellence for pancreatitis, pancreatic cancer”
7. Annals of Surgical Oncology, “Association of Cancer Center Designation with Multimodality Treatment, Perioperative Outcomes, and Survival among Older Adults with Pancreatic Ductal Adenocarcinoma”
8. National Cancer Institute, “Find a Cancer Center”
9. The University of Texas MD Anderson Cancer Center, “Pancreatic Cancer”
10. Johns Hopkins Medicine, “Pancreatic Cancer Treatment”
11. Memorial Sloan Kettering Cancer Center, “Pancreatic Cancer”
12. UCSF Health, “Pancreatic Cancer”
13. Dana-Farber Cancer Institute, “Pancreatic Cancer”
14. Cleveland Clinic, “Pancreatic Cancer”
15. Duke Health, “Pancreatic Cancer”
16. American Cancer Society, “Treating Pancreatic Cancer”